https://www.tradingview.com/chart/LxxJ4Dp1/?symbol=NASDAQ%3AHUGE
FSD Pharma has been ahead of the bearish behaviors we are beginning to see in heavily weighted areas of the market. On top of that, the entire cannabis sector of the market has been experiencing this type of behavior quite some time way before these big sell offs in fear of inflation rates and interest. Now keep in mind once these sell offs find their bottom, we will see a huge turn around in the buying power and influx of new retail investors and hedge funds.
These purchases are going to mainly be going towards what has been UNDERVALUED the LONGEST. which again falls into the cannabis timeline.
Not to mention FSD is currently undergoing a buyback on a portion of outstanding shares and is fresh off of a recent acquisition of LUCID, which will be conducting 2 of the 3 main psychopharmaceutical initiatives to apparently be a huge stepping stone in treating certain disorders and neuro- inflammatory diseases of the brain, from anxiety and depression to MS. Not to mention various other autoimmune disorders.
I believe there is a very large rebound given my analysis using certain variables from the Hertz wave theory (rev). Potentially another large sell-off and (3rd) breakthrough outside the channel could result in this bear run to finally bottom out and show an increase in value over the next few years, along with their advancements and contributions to the medical and psycho-medicinal community .
FSD Pharma has been ahead of the bearish behaviors we are beginning to see in heavily weighted areas of the market. On top of that, the entire cannabis sector of the market has been experiencing this type of behavior quite some time way before these big sell offs in fear of inflation rates and interest. Now keep in mind once these sell offs find their bottom, we will see a huge turn around in the buying power and influx of new retail investors and hedge funds.
These purchases are going to mainly be going towards what has been UNDERVALUED the LONGEST. which again falls into the cannabis timeline.
Not to mention FSD is currently undergoing a buyback on a portion of outstanding shares and is fresh off of a recent acquisition of LUCID, which will be conducting 2 of the 3 main psychopharmaceutical initiatives to apparently be a huge stepping stone in treating certain disorders and neuro- inflammatory diseases of the brain, from anxiety and depression to MS. Not to mention various other autoimmune disorders.
I believe there is a very large rebound given my analysis using certain variables from the Hertz wave theory (rev). Potentially another large sell-off and (3rd) breakthrough outside the channel could result in this bear run to finally bottom out and show an increase in value over the next few years, along with their advancements and contributions to the medical and psycho-medicinal community .
הערה:
*Elliot's Wave Theory . (Rev)
הערה:
Inflation reports highest rates since 1980's , large sell offs continue to happen alongside growing fears of Russian invasion on Ukraine . Could FSD be ahead of rebound ?
הערה:
FSD Pharma and it's subsidiaries have progress in advancing their three drug candidates (PEA, Lycid Psych. & Lucid MS) through clinical phases. After partnering with covar pharmaceuticals and Acquiring Lucid Psycheceuticals (subsidiary of FSD pharma Inc.), HUGE was able to recently purchase a new facility in Cobourg Ontario (CAD $17 million) which will be closing of May 31st. Selloff has leveled out .